Clinical Trials
50 trials registered for Phenylketonuria
Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3)
NCT05764239Phase 3Synlogic
Terminated↗
Long-Term Tetrahydrobiopterin Treatment in PKU Patients of 0-18 Years - Study on Phenylalanine Tolerance and Safety
NCT00432822Phase 2/3Orphanetics Pharma Entwicklungs GmbH
Terminated↗
Moderate Intensity Exercise and Phenylketonuria
NCT01904708N/AOregon Health and Science University
Terminated↗
Safety and Efficacy of HMI-103 in Participants With Classical PKU Due to PAH Deficiency
NCT05222178Phase 1Homology Medicines, Inc
Terminated↗
Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria
NCT01977820Phase 2BioMarin Pharmaceutical
Terminated↗
A Study Into the Future Cardiovascular Disease (CVD) Risk of Phenylketonuria (PKU) Patients on a Low Phenylalanine Treatment Diet (LPD).
NCT04251494N/AGuy's and St Thomas' NHS Foundation Trust
Unknown↗
Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®)
NCT05894122N/AUniversity Hospital, Grenoble
Unknown↗
A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria
NCT06147856Phase 1/2ModernaTX, Inc.
Withdrawn↗
PKU Low Calorie Drink Study
NCT04272736N/ANutricia UK Ltd
Withdrawn↗
Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CDX 6114 in PKU Patients
NCT04256655Phase 1Société des Produits Nestlé (SPN)
Withdrawn↗